Nu-Med Plus' market value is the price at which a share of Nu-Med Plus trades on a public exchange. It measures the collective expectations of Nu Med Plus investors about its performance. Nu-Med Plus is trading at 0.0123 as of the 31st of December 2024, a 29.71 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0123. With this module, you can estimate the performance of a buy and hold strategy of Nu Med Plus and determine expected loss or profit from investing in Nu-Med Plus over a given investment horizon. Check out Nu-Med Plus Correlation, Nu-Med Plus Volatility and Nu-Med Plus Alpha and Beta module to complement your research on Nu-Med Plus.
Please note, there is a significant difference between Nu-Med Plus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nu-Med Plus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nu-Med Plus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Nu-Med Plus 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nu-Med Plus' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nu-Med Plus.
0.00
02/05/2024
No Change 0.00
0.0
In 10 months and 27 days
12/31/2024
0.00
If you would invest 0.00 in Nu-Med Plus on February 5, 2024 and sell it all today you would earn a total of 0.00 from holding Nu Med Plus or generate 0.0% return on investment in Nu-Med Plus over 330 days. Nu-Med Plus is related to or competes with Biomerica, Accuray Incorporated, Rapid Micro, SINTX Technologies, STRATA Skin, Nuwellis, and Helius Medical. Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of m... More
Nu-Med Plus Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nu-Med Plus' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nu Med Plus upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nu-Med Plus' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nu-Med Plus' standard deviation. In reality, there are many statistical measures that can use Nu-Med Plus historical prices to predict the future Nu-Med Plus' volatility.
Nu Med Plus retains Efficiency (Sharpe Ratio) of -0.0759, which conveys that the firm had a -0.0759% return per unit of price deviation over the last 3 months. Nu-Med Plus exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nu-Med Plus' Information Ratio of (0.06), mean deviation of 7.63, and Market Risk Adjusted Performance of (0.44) to check out the risk estimate we provide. The company owns a Beta (Systematic Risk) of 1.76, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nu-Med Plus will likely underperform. At this point, Nu Med Plus has a negative expected return of -1.04%. Please make sure to verify Nu-Med Plus' jensen alpha and the relationship between the value at risk and day typical price , to decide if Nu Med Plus performance from the past will be repeated at future time.
Auto-correlation
-0.22
Weak reverse predictability
Nu Med Plus has weak reverse predictability. Overlapping area represents the amount of predictability between Nu-Med Plus time series from 5th of February 2024 to 19th of July 2024 and 19th of July 2024 to 31st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nu Med Plus price movement. The serial correlation of -0.22 indicates that over 22.0% of current Nu-Med Plus price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.22
Spearman Rank Test
-0.42
Residual Average
0.0
Price Variance
0.0
Nu Med Plus lagged returns against current returns
Autocorrelation, which is Nu-Med Plus otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Nu-Med Plus' otc stock expected returns. We can calculate the autocorrelation of Nu-Med Plus returns to help us make a trade decision. For example, suppose you find that Nu-Med Plus has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Nu-Med Plus regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Nu-Med Plus otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Nu-Med Plus otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Nu-Med Plus otc stock over time.
Current vs Lagged Prices
Timeline
Nu-Med Plus Lagged Returns
When evaluating Nu-Med Plus' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Nu-Med Plus otc stock have on its future price. Nu-Med Plus autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Nu-Med Plus autocorrelation shows the relationship between Nu-Med Plus otc stock current value and its past values and can show if there is a momentum factor associated with investing in Nu Med Plus.
Regressed Prices
Timeline
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Nu-Med OTC Stock
Nu-Med Plus financial ratios help investors to determine whether Nu-Med OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nu-Med with respect to the benefits of owning Nu-Med Plus security.